Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument
- 6 Citations
- 1.9k Downloads
Abstract
Increasing sample numbers for screening and diagnostics using circulating cell-free DNA (ccfDNA) as analyte demands an automated solution for ccfDNA extraction. The efficiency of a new, automated, large volume ccfDNA extraction method was evaluated against a manual reference method. The new kit for automated ccfDNA extraction on the QIAsymphony showed a comparable yield of total ccfDNA from healthy donors as well as a comparable recovery of circulating cancer and fetal DNA. In conclusion, a new kit for automated ccfDNA extraction was established successfully.
Keywords
ccfDNA Automation Fetal Cancer QIAsymphony QIAGENNotes
Conflict of Interest
Work presented here was funded by QIAGEN’s R&D Department. A. Wolf and K. Beller are employees of QIAGEN GmbH. S. Groemminger, W. Hofmann and M. Sachse are employees of LifeCodexx AG. J. Fassunke is an employee of Universitätsklinikum Köln.